Header Logo

Leslie Harrold

Concepts (372)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
68
2025
324
16.140
Why?
Antirheumatic Agents
58
2024
213
14.190
Why?
Gout
18
2020
53
5.350
Why?
Tumor Necrosis Factor-alpha
22
2024
584
3.670
Why?
Gout Suppressants
11
2020
25
3.310
Why?
Biological Products
12
2024
94
3.020
Why?
Registries
39
2025
811
2.870
Why?
Medication Adherence
13
2018
245
2.680
Why?
Rituximab
4
2017
82
2.040
Why?
Abatacept
5
2024
63
2.010
Why?
Severity of Illness Index
30
2025
1470
1.890
Why?
Rheumatology
11
2020
65
1.860
Why?
Middle Aged
87
2025
16545
1.830
Why?
Aged
82
2025
13585
1.830
Why?
Arthritis, Psoriatic
6
2024
31
1.760
Why?
Male
101
2025
27969
1.640
Why?
Practice Patterns, Physicians'
11
2016
718
1.580
Why?
Female
102
2025
31235
1.530
Why?
Treatment Outcome
38
2024
5264
1.490
Why?
Health Knowledge, Attitudes, Practice
6
2020
743
1.410
Why?
United States
35
2025
7609
1.360
Why?
Sjogren's Syndrome
2
2020
26
1.350
Why?
Humans
133
2025
60133
1.340
Why?
Anti-Citrullinated Protein Antibodies
2
2019
6
1.260
Why?
Guideline Adherence
6
2020
298
1.150
Why?
Adult
52
2024
15982
1.110
Why?
Disease Progression
6
2025
1054
1.110
Why?
Antibodies, Monoclonal
8
2019
854
1.080
Why?
Etanercept
7
2019
32
1.050
Why?
Adalimumab
6
2019
36
1.010
Why?
Methotrexate
7
2022
76
0.990
Why?
Pyrroles
1
2024
50
0.940
Why?
Piperidines
1
2024
50
0.930
Why?
Pyrimidines
1
2024
124
0.900
Why?
Protein Kinase Inhibitors
1
2024
171
0.870
Why?
Rheumatologists
4
2020
7
0.840
Why?
Health Resources
3
2019
88
0.830
Why?
Prescription Drugs
2
2013
50
0.820
Why?
Prospective Studies
13
2025
3131
0.780
Why?
Churg-Strauss Syndrome
3
2007
15
0.760
Why?
Anti-Inflammatory Agents, Non-Steroidal
5
2021
199
0.760
Why?
Colchicine
4
2020
27
0.740
Why?
Attitude of Health Personnel
3
2018
568
0.700
Why?
Quality of Health Care
4
2015
524
0.670
Why?
Follow-Up Studies
11
2019
2361
0.640
Why?
Cohort Studies
20
2019
2477
0.640
Why?
Health Maintenance Organizations
5
2010
87
0.630
Why?
Aged, 80 and over
26
2018
5194
0.610
Why?
Remission Induction
9
2020
139
0.600
Why?
Managed Care Programs
3
2013
94
0.600
Why?
Antibodies, Monoclonal, Humanized
4
2016
225
0.600
Why?
Time Factors
18
2021
3621
0.600
Why?
Patient Compliance
3
2010
373
0.600
Why?
Certolizumab Pegol
1
2018
2
0.600
Why?
Immunoglobulin Fab Fragments
1
2017
34
0.580
Why?
Inservice Training
1
2018
85
0.570
Why?
Drug Substitution
2
2016
42
0.570
Why?
Education, Medical, Continuing
1
2018
100
0.560
Why?
Biological Factors
1
2016
23
0.540
Why?
Depression
5
2016
867
0.540
Why?
Proportional Hazards Models
11
2019
679
0.520
Why?
Anti-Asthmatic Agents
2
2007
30
0.520
Why?
Precision Medicine
1
2017
105
0.510
Why?
Osteoarthritis
3
2008
132
0.500
Why?
Patient Reported Outcome Measures
5
2020
125
0.490
Why?
Sex Characteristics
1
2017
199
0.490
Why?
Drug Costs
2
2013
59
0.490
Why?
Bacterial Infections
1
2016
137
0.490
Why?
Patient Acceptance of Health Care
1
2019
455
0.480
Why?
Ambulatory Care
3
2014
306
0.460
Why?
Practice Guidelines as Topic
5
2016
712
0.440
Why?
Prevalence
9
2020
1295
0.440
Why?
Immunoconjugates
1
2013
84
0.430
Why?
Psoriasis
3
2020
51
0.430
Why?
Arthritis, Juvenile
1
2013
8
0.430
Why?
Drug Therapy, Combination
5
2024
436
0.420
Why?
Algorithms
6
2016
1004
0.420
Why?
Surveys and Questionnaires
13
2020
2614
0.420
Why?
Incidence
11
2019
1266
0.400
Why?
Culture
1
2012
76
0.400
Why?
Disease Management
4
2020
222
0.390
Why?
Asthma
2
2007
423
0.390
Why?
Multivariate Analysis
8
2019
928
0.390
Why?
Retrospective Studies
13
2019
6136
0.380
Why?
Drug-Related Side Effects and Adverse Reactions
6
2013
152
0.370
Why?
Population Surveillance
1
2012
206
0.370
Why?
Drug Delivery Systems
1
2014
311
0.370
Why?
Primary Health Care
4
2016
660
0.360
Why?
Health Expenditures
1
2012
118
0.360
Why?
Hospitalization
5
2016
1304
0.350
Why?
Pain Measurement
7
2019
336
0.350
Why?
Self Care
1
2012
212
0.350
Why?
Spondylitis, Ankylosing
2
2024
24
0.350
Why?
Anticoagulants
5
2012
488
0.350
Why?
Chi-Square Distribution
5
2019
406
0.350
Why?
Nursing Homes
7
2015
660
0.340
Why?
Odds Ratio
5
2023
773
0.340
Why?
Uric Acid
5
2019
49
0.340
Why?
Age Factors
9
2017
1526
0.330
Why?
Hyperuricemia
2
2019
8
0.330
Why?
Glucocorticoids
4
2023
172
0.320
Why?
Health Surveys
5
2017
311
0.320
Why?
Arthroplasty, Replacement, Knee
3
2016
128
0.310
Why?
Linear Models
3
2018
423
0.310
Why?
Polyarteritis Nodosa
1
2008
3
0.300
Why?
Consensus
3
2019
199
0.300
Why?
Pancytopenia
1
2008
7
0.300
Why?
Propensity Score
3
2018
138
0.300
Why?
Insurance Claim Review
2
2012
80
0.300
Why?
Spondylarthritis
2
2020
41
0.300
Why?
Risk Factors
9
2019
5087
0.290
Why?
Disability Evaluation
5
2015
217
0.290
Why?
Rheumatic Diseases
1
2008
41
0.290
Why?
Accidents, Occupational
1
2008
55
0.290
Why?
Uricosuric Agents
2
2020
2
0.280
Why?
Myocardial Infarction
3
2013
869
0.280
Why?
Allopurinol
4
2020
17
0.270
Why?
Cross-Sectional Studies
7
2017
2501
0.270
Why?
Long-Term Care
3
2008
176
0.270
Why?
Symptom Assessment
2
2017
39
0.270
Why?
Pain
3
2020
403
0.270
Why?
Databases, Factual
10
2019
849
0.260
Why?
Logistic Models
3
2019
1260
0.260
Why?
Dose-Response Relationship, Drug
5
2019
805
0.260
Why?
Prognosis
4
2018
1591
0.260
Why?
Chronic Disease
4
2015
744
0.260
Why?
Health Status
4
2020
451
0.250
Why?
Predictive Value of Tests
9
2015
1035
0.250
Why?
Warfarin
3
2012
110
0.250
Why?
Research Design
3
2024
569
0.240
Why?
Wounds and Injuries
1
2008
243
0.240
Why?
Adipokines
1
2024
28
0.240
Why?
Quality of Life
4
2020
1139
0.240
Why?
Cluster Analysis
4
2023
252
0.230
Why?
Kaplan-Meier Estimate
3
2017
391
0.230
Why?
Feasibility Studies
2
2018
531
0.230
Why?
Arthralgia
2
2015
61
0.220
Why?
Knee Joint
3
2016
288
0.220
Why?
Massachusetts
7
2014
2119
0.220
Why?
Self Report
3
2016
369
0.220
Why?
Immunoglobulin G
4
2012
450
0.210
Why?
Delphi Technique
3
2019
84
0.210
Why?
Renal Insufficiency, Chronic
1
2025
118
0.210
Why?
Metabolic Syndrome
1
2024
149
0.210
Why?
Case-Control Studies
3
2020
1066
0.210
Why?
Diabetes Mellitus
2
2019
537
0.210
Why?
Cost of Illness
1
2024
157
0.210
Why?
Sex Factors
5
2013
970
0.200
Why?
Neoplasms
3
2022
1262
0.200
Why?
Angioplasty, Balloon, Coronary
1
2003
167
0.200
Why?
Drug Administration Schedule
5
2019
280
0.200
Why?
Patient Selection
2
2015
453
0.200
Why?
Adolescent
10
2016
5958
0.200
Why?
Validation Studies as Topic
2
2012
22
0.190
Why?
Attitude
1
2002
101
0.190
Why?
Health Services
1
2002
85
0.190
Why?
Sulfasalazine
1
2021
5
0.190
Why?
Databases as Topic
3
2007
53
0.190
Why?
Obesity
3
2022
1191
0.190
Why?
North America
3
2016
115
0.190
Why?
Hydroxychloroquine
1
2021
21
0.190
Why?
Quality Improvement
2
2017
428
0.190
Why?
Cardiac Catheterization
1
2003
254
0.190
Why?
Antipsychotic Agents
2
2015
313
0.190
Why?
Coronary Artery Bypass
1
2003
276
0.180
Why?
Homes for the Aged
3
2012
163
0.180
Why?
Cardiovascular Diseases
2
2022
831
0.180
Why?
Joints
3
2012
32
0.180
Why?
Comorbidity
3
2020
1097
0.180
Why?
Osteoarthritis, Knee
2
2016
386
0.180
Why?
Diphosphonates
2
2010
35
0.170
Why?
Delivery of Health Care
2
2016
424
0.170
Why?
Receptors, Tumor Necrosis Factor
4
2012
62
0.170
Why?
Women's Health
1
2003
390
0.170
Why?
Ustekinumab
1
2020
5
0.170
Why?
Infliximab
4
2012
55
0.170
Why?
Adverse Drug Reaction Reporting Systems
4
2012
50
0.170
Why?
Monitoring, Physiologic
2
2019
151
0.170
Why?
Dermatologic Agents
1
2019
21
0.170
Why?
Medicare
4
2023
599
0.160
Why?
Fatigue
1
2020
104
0.160
Why?
Health Care Costs
2
2016
210
0.160
Why?
Crystal Arthropathies
1
2019
1
0.160
Why?
Physician-Patient Relations
2
2020
395
0.160
Why?
Range of Motion, Articular
1
2019
87
0.150
Why?
Terminology as Topic
1
2019
138
0.150
Why?
Diuretics
2
2017
58
0.150
Why?
Recurrence
2
2017
600
0.150
Why?
Socioeconomic Factors
2
2013
790
0.150
Why?
Health Care Surveys
2
2013
281
0.140
Why?
Statistics, Nonparametric
1
2017
209
0.140
Why?
Immunosuppressive Agents
1
2019
304
0.140
Why?
Patient Care Planning
1
2017
83
0.140
Why?
Clinical Decision-Making
1
2018
142
0.140
Why?
Behavioral Risk Factor Surveillance System
2
2008
48
0.140
Why?
Preoperative Period
1
2016
61
0.130
Why?
Nursing Staff
2
2013
41
0.130
Why?
Patients
2
2013
103
0.120
Why?
Drug Utilization
2
2015
221
0.120
Why?
Age Distribution
2
2008
262
0.120
Why?
Retreatment
1
2015
46
0.120
Why?
Medication Errors
5
2012
116
0.120
Why?
Marketing of Health Services
1
2015
23
0.120
Why?
California
4
2016
162
0.120
Why?
Heart Failure
2
2012
868
0.110
Why?
Immunologic Factors
2
2012
98
0.110
Why?
Confidence Intervals
2
2007
257
0.110
Why?
Medicare Part B
2
2012
10
0.110
Why?
Sensitivity and Specificity
5
2013
1100
0.110
Why?
Office Visits
1
2014
42
0.110
Why?
Acute Disease
2
2013
661
0.110
Why?
Longitudinal Studies
5
2016
1239
0.110
Why?
Medical Staff
1
2013
14
0.110
Why?
Risk Assessment
4
2019
1934
0.110
Why?
Arthroplasty, Replacement
1
2013
15
0.110
Why?
Osteoporosis
2
2012
139
0.110
Why?
Child, Preschool
3
2013
1850
0.110
Why?
Administrative Personnel
1
2013
33
0.110
Why?
Autoimmune Diseases
2
2012
223
0.110
Why?
Connecticut
4
2015
87
0.100
Why?
Insurance, Pharmaceutical Services
1
2013
24
0.100
Why?
Patient Discharge
2
2014
483
0.100
Why?
Diagnosis, Computer-Assisted
1
2013
44
0.100
Why?
Seafood
1
2012
18
0.100
Why?
Dementia
2
2013
252
0.100
Why?
Continuity of Patient Care
1
2014
173
0.100
Why?
Perception
1
2013
179
0.100
Why?
Sampling Studies
1
2012
66
0.100
Why?
Sex Distribution
2
2003
255
0.100
Why?
Meat
1
2012
44
0.100
Why?
Medicare Part D
1
2012
34
0.100
Why?
Health Status Disparities
1
2013
146
0.100
Why?
Lung Diseases, Interstitial
1
2013
94
0.100
Why?
Income
1
2013
162
0.100
Why?
Osteoporotic Fractures
1
2012
32
0.100
Why?
Hypertension
1
2017
601
0.090
Why?
Attitude to Health
1
2013
280
0.090
Why?
ROC Curve
2
2009
260
0.090
Why?
Life Style
1
2013
330
0.090
Why?
Guidelines as Topic
1
2012
157
0.090
Why?
Qualitative Research
2
2017
633
0.090
Why?
Ischemic Attack, Transient
1
2012
91
0.090
Why?
Electronic Health Records
1
2014
352
0.090
Why?
Quality Indicators, Health Care
1
2013
331
0.090
Why?
Drug Prescriptions
1
2012
190
0.090
Why?
Bone Density Conservation Agents
1
2010
49
0.090
Why?
Patient Satisfaction
3
2013
419
0.090
Why?
Alcohol Drinking
1
2012
305
0.080
Why?
Clinical Protocols
1
2011
137
0.080
Why?
Patient Readmission
1
2014
424
0.080
Why?
Bone Resorption
1
2010
49
0.080
Why?
Professional-Patient Relations
1
2010
128
0.080
Why?
Probability
1
2010
173
0.080
Why?
Sulfinpyrazone
1
2009
3
0.080
Why?
Probenecid
1
2009
6
0.080
Why?
Fractures, Bone
1
2010
149
0.080
Why?
Child
3
2013
4333
0.080
Why?
Exercise
1
2016
919
0.080
Why?
Clinical Competence
1
2013
699
0.080
Why?
Medical Order Entry Systems
1
2008
45
0.080
Why?
Interviews as Topic
1
2010
495
0.070
Why?
Job Description
1
2008
22
0.070
Why?
New Hampshire
1
2008
42
0.070
Why?
Risk
3
2013
377
0.070
Why?
Feeding Behavior
1
2010
314
0.070
Why?
Diet
1
2012
637
0.070
Why?
Leukotriene Antagonists
1
2007
9
0.070
Why?
Young Adult
5
2016
4395
0.070
Why?
Motivation
1
2010
270
0.070
Why?
Decision Support Techniques
1
2008
183
0.070
Why?
Patient Education as Topic
1
2010
450
0.070
Why?
International Normalized Ratio
3
2012
35
0.070
Why?
Stroke
2
2013
1144
0.070
Why?
Data Collection
1
2008
382
0.060
Why?
Communication
1
2011
558
0.060
Why?
Diagnostic Errors
1
2007
98
0.060
Why?
Adrenal Cortex Hormones
1
2007
157
0.060
Why?
Disabled Persons
1
2008
205
0.060
Why?
Creatinine
1
2006
123
0.060
Why?
Physical Examination
2
2016
103
0.060
Why?
Total Quality Management
1
2005
57
0.060
Why?
Adiponectin
1
2024
34
0.060
Why?
Arthritis
1
2005
50
0.060
Why?
Glomerular Filtration Rate
1
2025
95
0.060
Why?
Leptin
1
2024
79
0.060
Why?
Mental Processes
1
2023
18
0.050
Why?
Concept Formation
1
2023
16
0.050
Why?
Drug Monitoring
3
2012
96
0.050
Why?
Activities of Daily Living
2
2016
300
0.050
Why?
Prescriptions
1
2023
33
0.050
Why?
Group Practice
1
2003
12
0.050
Why?
Multicenter Studies as Topic
1
2023
121
0.050
Why?
Drug Therapy
1
2003
61
0.050
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2003
142
0.050
Why?
Necrosis
1
2022
140
0.050
Why?
Adrenergic beta-Antagonists
1
2003
149
0.050
Why?
Exercise Test
1
2003
237
0.050
Why?
Aspirin
1
2003
172
0.050
Why?
International Classification of Diseases
2
2013
143
0.050
Why?
Fibrinolytic Agents
1
2003
165
0.050
Why?
Thrombolytic Therapy
1
2003
182
0.050
Why?
Internet
1
2005
465
0.050
Why?
Health Behavior
1
2005
472
0.050
Why?
Physician's Role
1
2002
120
0.050
Why?
Biomarkers
2
2017
1214
0.040
Why?
Thalidomide
1
2020
33
0.040
Why?
Febuxostat
1
2020
2
0.040
Why?
Symptom Flare Up
1
2020
13
0.040
Why?
Echocardiography
1
2003
460
0.040
Why?
Healthy Lifestyle
1
2020
29
0.040
Why?
Biological Therapy
1
2020
16
0.040
Why?
Goals
1
2020
91
0.040
Why?
Interdisciplinary Placement
1
2018
1
0.040
Why?
Infant, Newborn
2
2013
1312
0.040
Why?
Medical Records
2
2012
139
0.040
Why?
Patient Preference
1
2018
77
0.040
Why?
Infant
2
2013
1532
0.040
Why?
Waiting Lists
1
2017
48
0.030
Why?
Computers
1
2016
48
0.030
Why?
Medical Records Systems, Computerized
1
2016
66
0.030
Why?
Patient Outcome Assessment
1
2016
55
0.030
Why?
Knee Injuries
1
2016
49
0.030
Why?
Cooperative Behavior
1
2017
220
0.030
Why?
Learning
1
2017
173
0.030
Why?
Accelerometry
1
2016
59
0.030
Why?
Health Facility Size
1
2015
17
0.030
Why?
Decision Making
1
2018
394
0.030
Why?
Body Mass Index
1
2019
892
0.030
Why?
Comparative Effectiveness Research
1
2014
46
0.030
Why?
Elective Surgical Procedures
1
2015
108
0.030
Why?
Time-to-Treatment
1
2015
99
0.030
Why?
Biomechanical Phenomena
1
2015
247
0.030
Why?
Least-Squares Analysis
1
2013
24
0.030
Why?
New Zealand
1
2013
34
0.030
Why?
New England
2
2004
268
0.030
Why?
Myocardial Revascularization
1
2013
72
0.030
Why?
Evidence-Based Practice
1
2013
82
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2012
36
0.030
Why?
Clinical Coding
1
2013
43
0.030
Why?
Inappropriate Prescribing
1
2013
67
0.030
Why?
Poisson Distribution
1
2012
52
0.030
Why?
Urban Population
1
2013
185
0.030
Why?
Needs Assessment
1
2013
192
0.020
Why?
Self Efficacy
1
2013
199
0.020
Why?
Health Services Research
1
2013
270
0.020
Why?
Recovery of Function
1
2013
267
0.020
Why?
Absorptiometry, Photon
1
2012
89
0.020
Why?
Delivery of Health Care, Integrated
1
2013
116
0.020
Why?
Regression Analysis
1
2012
483
0.020
Why?
Mortality
1
2012
165
0.020
Why?
Evidence-Based Medicine
1
2013
457
0.020
Why?
Bone Density
1
2012
174
0.020
Why?
Telephone
1
2011
121
0.020
Why?
Administration, Oral
1
2010
344
0.020
Why?
Quality Assurance, Health Care
1
2011
248
0.020
Why?
Emergency Service, Hospital
1
2016
1038
0.020
Why?
Inflammation
1
2014
1112
0.020
Why?
Reproducibility of Results
1
2012
1564
0.020
Why?
Physicians
1
2013
442
0.020
Why?
Hemorrhage
1
2007
272
0.020
Why?
Epidemiologic Methods
1
2005
69
0.010
Why?
Drug Interactions
1
2005
113
0.010
Why?
Insurance, Health
1
2006
143
0.010
Why?
Self Concept
1
2005
104
0.010
Why?
Analgesics, Non-Narcotic
1
2004
35
0.010
Why?
Ambulatory Care Facilities
1
2004
103
0.010
Why?
Anticonvulsants
1
2004
94
0.010
Why?
Patient Participation
1
2005
214
0.010
Why?
Medicare Part C
1
2003
17
0.010
Why?
Diagnosis, Differential
1
2005
910
0.010
Why?
Software
1
2005
376
0.010
Why?
Pharmaceutical Preparations
1
2003
121
0.010
Why?
Harrold's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (372)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_